TrialJournal of translational medicine2016

Patient-derived xenografts faithfully replicated clinical outcome in a phase II co-clinical trial of arsenic trioxide in relapsed small cell lung cancer.

Taofeek K Owonikoko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.